Brian Berman, MD, MS

Professor Adjoint, Neurology

FacultyPhoto

Download CV

Medical School
  • MD, University of Colorado Denver School of Medicine (2004)
Graduate School
  • MS, University of Colorado Denver (1996)
Undergraduate School
  • BS, University of New Mexico (NM) (1992)
Internship
  • University of California (San Francisco) School of Medicine Program (2005)
Residency
  • University of California (San Francisco) School of Medicine Program, Neurology (2008)
Fellowships
  • National Institutes of Health (NIH), Neurology (2010)
Languages
English
Department
Neurology

Professional Titles

  • Chair, Radioactive Drug Research Committee

Recognitions

  • Department of Neurology Faculty Student Teaching Appreciation Award, University of Colorado School of Medicine (2016)
  • Fellow, American Academy of Neurology (2018)
  • Golden Stethoscope Award: Patient/Physician Communication., University of Colorado School of Medicine (2018)

Research Interests

My research includes using advanced brain imaging methods to study what happens to brain structure and function when a patient develops Parkinson’s disease or dystonia so that we can make better and earlier diagnoses, find better ways to treat these disorders, and advance our knowledge of what causes these disorders so that we can eventually find their cures.

Publications

  • Berman B. “Neuroleptic malignant syndrome: A review for neurohospitalists.” The Neurohospitalist, 2011 Jan;1(1):41-7.
  • Benninger D, Berman B, Houdayer E, Pal N, Luckenbaugh D, Schneider L, Miranda S, Hallett M. “Intermittent Theta-Burst Transcranial Magnetic Stimulation for Treatment of Parkinson’s Disease: A Randomized, Double-Blind, Sham-Controlled Study.” Neurology, 2011 Feb 15;76(7):601-9.
  • Berman B, Horovitz S, Morel B, Hallett M. “Neural correlates of blink suppression and the buildup of a natural bodily urge." NeuroImage, 2012;59:1441-50.
  • Berman B, Horovitz S, Venkataram G, Hallett M. “Modulation of primary motor cortex activity with real-time fMRI-based neurofeedback during motor and motor imagery tasks.” NeuroImage, 2012;59:917-25.
  • Berman BD, Hallett M, Herscovitch P, Simonyan K. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp. Brain. 2013 Dec;136(Pt 12):3645-58. PubMed PMID: 24148273
  • Berman BD, Horovitz SG, Hallett M. Modulation of functionally localized right insular cortex activity using real-time fMRI-based neurofeedback. Front Hum Neurosci. 2013;7:638. PubMed PMID: 24133436
  • Simonyan K, Berman BD, Herscovitch P, Hallett M. Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci. 2013 Sep 11;33(37):14705-14. PubMed PMID: 24027271
  • "Writer's Cramp." In Kumar A (Ed): Textbook of Movement Disorders (1st Edition). New Delhi: Jaypee Brothers (P) Ltd., 2013, 250-6.
  • Kennel C, Michas-Martin A, Berman BD, Poisson S. Nonconvulsive status epilepticus masquerading as stroke. Am J Emerg Med. 2014 Aug 29. [Epub ahead of print] PubMed PMID: 25239692
  • Nyberg EM, Tanabe J, Honce JM, Krmpotich T, Shelton E, Hedeman J, Berman BD. Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes. Parkinsonism Relat Disord. 2015 May;21(5):536-40. PubMed PMID: 25817514
  • Berman BD, Jinnah HA. Dystonia: Five new things. Neurol Clin Pract. 2015 Jun;5(3):232-240. PubMed PMID: 26124980
  • Emmert K, Kopel R, Sulzer J, Brühl AB, Berman BD, Linden DE, Horovitz SG, Breimhorst M, Caria A, Frank S, Johnston S, Long Z, Paret C, Robineau F, Veit R, Bartsch A, Beckmann CF, Van De Ville D, Haller S. Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?. Neuroimage. 2016 Jan 1;124(Pt A):806-12. PubMed PMID: 26419389
  • Kennel C, Michas-Martin A, Berman BD, Poisson S. Non convulsive status epilepticus masquerading as stroke. Am J Emerg Med. 2015 Mar;33(3):482.e1-2. PubMed PMID: 25239692
  • Pollard R, Hannan M, Tanabe J, Berman BD. Early-onset Parkinson disease leading to diagnosis of 22q11.2 deletion syndrome. Parkinsonism Relat Disord. 2016 Apr;25:110-1. PubMed PMID: 26868161
  • Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD. Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes. Front Neuroanat. 2016 Feb 23;10:17. PubMed PMID: 26941615
  • LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurol Genet. 2016 Apr 11;2(3):e69. PubMed PMID: 27123488
  • Berman BD, Smucny J, Wylie KP, Shelton E, Kronberg E, Leehey M, Tregellas JR. Levodopa modulates small-world architecture of functional brain networks in Parkinson's disease. Mov Disord. 2016 Nov;31(11):1676-1684. PubMed PMID: 27461405
  • Pratt D, Mente K, Rahimpour S, Edwards NA, Tinaz S, Berman BD, Hallett M, Ray-Chaudhury A. Diminishing evidence for torsinA-positive neuronal inclusions in DYT1 dystonia. Acta Neuropathol Commun. 2016 Aug 17;4(1):85. PubMed PMID: 27531128
  • Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Mov Disord. 2016 Dec;31(12):1874-1882. PubMed PMID: 27753188
  • Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD. Botulinum toxin for motor and phonic tics in Tourette's syndrome (Protocol). Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD012285. DOI: 10.1002/14651858.CD012285.
  • Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602. PubMed PMID: 28438790
  • Mohl B, Berman BD, Shelton E, Tanabe J. Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study. J Comp Neurol. 2017 Jun 15;525(9):2192-2201. PubMed PMID: 28256710
  • Norris SA, Jinnah HA, Espay AJ, Klein C, Brüggemann N, Barbano RL, Malaty IA, Rodriguez RL, Vidailhet M, Roze E, Reich SG, Berman BD, LeDoux MS, Richardson SP, Agarwal P, Mari Z, Ondo WG, Shih LC, Fox SH, Berardelli A, Testa CM, Cheng FC, Truong D, Nahab FB, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Mov Disord. 2016 Dec;31(12):1874-1882. PubMed PMID: 27753188
  • Pratt D, Mente K, Rahimpour S, Edwards NA, Tinaz S, Berman BD, Hallett M, Ray-Chaudhury A. Diminishing evidence for torsinA-positive neuronal inclusions in DYT1 dystonia. Acta Neuropathol Commun. 2016 Aug 17;4(1):85. PubMed PMID: 27531128
  • Berman BD, Smucny J, Wylie KP, Shelton E, Kronberg E, Leehey M, Tregellas JR. Levodopa modulates small-world architecture of functional brain networks in Parkinson's disease. Mov Disord. 2016 Nov;31(11):1676-1684. PubMed PMID: 27461405
  • LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah HA, Rosen AR, Hedera P, Comella CL, Weissbach A, Junker J, Jankovic J, Barbano RL, Reich SG, Rodriguez RL, Berman BD, Chouinard S, Severt L, Agarwal P, Stover NP. Clinical and genetic features of cervical dystonia in a large multicenter cohort. Neurol Genet. 2016 Jun;2(3):e69. PubMed PMID: 27123488
  • Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD. Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes. Front Neuroanat. 2016;10:17. PubMed PMID: 26941615
  • Pollard R, Hannan M, Tanabe J, Berman BD. Early-onset Parkinson disease leading to diagnosis of 22q11.2 deletion syndrome. Parkinsonism Relat Disord. 2016 Apr;25:110-1. PubMed PMID: 26868161
  • Emmert K, Kopel R, Sulzer J, Brühl AB, Berman BD, Linden DEJ, Horovitz SG, Breimhorst M, Caria A, Frank S, Johnston S, Long Z, Paret C, Robineau F, Veit R, Bartsch A, Beckmann CF, Van De Ville D, Haller S. Meta-analysis of real-time fMRI neurofeedback studies using individual participant data: How is brain regulation mediated?. Neuroimage. 2016 Jan 1;124(Pt A):806-812. PubMed PMID: 26419389
  • Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Brüggemann N. Predictors of alcohol responsiveness in dystonia. Neurology. 2018 Oct 19. [Epub ahead of print] PubMed PMID: 30341158
  • Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease. Mov Disord. 2018 Oct 10. [Epub ahead of print] PubMed PMID: 30306618
  • Berman BD, Hawkins T. Author response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis. Neurol Clin Pract. 2018 Jun;8(3):175-176. PubMed PMID: 30105152
  • Berman BD, Honce JM, Shelton E, Sillau SH, Nagae LM. Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure. Neuroimage Clin. 2018;19:805-812. PubMed PMID: 30013924
  • Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS. Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2. Neurology. 2018 Jun 5;90(23):e2059-e2067. PubMed PMID: 29752303
  • Berman BD, Pollard RT, Shelton E, Karki R, Smith-Jones PM, Miao Y. GABA(A) Receptor Availability Changes Underlie Symptoms in Isolated Cervical Dystonia. Front Neurol. 2018;9:188. PubMed PMID: 29670567
  • Holden SK, Finseth T, Sillau SH, Berman BD. Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort. Mov Disord Clin Pract. 2018 Jan-Feb;5(1):47-53. PubMed PMID: 29662921
  • Groth CL, Berman BD. Spinocerebellar Ataxia 27: A Review and Characterization of an Evolving Phenotype. Tremor Other Hyperkinet Mov (N Y). 2018;8:534. PubMed PMID: 29416937
  • Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD. Botulinum toxin for motor and phonic tics in Tourette's syndrome. Cochrane Database Syst Rev. 2018 Jan 5;1:CD012285. PubMed PMID: 29304272
  • Schenkman M, Moore CG, Kohrt WM, Hall DA, Delitto A, Comella CL, Josbeno DA, Christiansen CL, Berman BD, Kluger BM, Melanson EL, Jain S, Robichaud JA, Poon C, Corcos DM. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018 Feb 1;75(2):219-226. PubMed PMID: 29228079
  • Merola A, Dwivedi AK, Shaikh AG, Tareen TK, Da Prat GA, Kauffman MA, Hampf J, Mahajan A, Marsili L, Jankovic J, Comella CL, Berman BD, Perlmutter JS, Jinnah HA, Espay AJ. Head tremor at disease onset: an ataxic phenotype of cervical dystonia. J Neurol. 2019 Aug;266(8):1844-1851. PubMed PMID: 31028543
  • McConnell BV, Kaplan RI, Teale PD, Kronberg E, Broussard JL, Guzetti JR, Sillau SH, Dhanasekaran AR, Kluger BM, Berman BD. Feasibility of home-based automated transcranial electrical stimulation during slow wave sleep. Brain Stimul. 2019 May - Jun;12(3):813-815. PubMed PMID: 30819658
  • Kletenik I, Sillau SH, Isfahani SA, LaFaver K, Hallett M, Berman BD. “Increased Prevalence of Functional Movement Disorders in Females: the role of sexual abuse.” Mov Disord Clin Pract (In press)
  • Berman BD, Feuerstein J, Groth CL. Imaging of movement disorders. In: Roos RP, editor-in-chief. MedLink Neurology. San Diego: MedLink Corporation. Available at www.medlink.com. Original content added February 9, 2017. Annual updates from 2017 – Present. Last updated: March 10, 2019.
  • Berman BD, Groth CL, Shelton E, Sillau SH, Sutton B, Legget KT, Tregellas JR. Hemodynamic responses are abnormal in isolated cervical dystonia. J Neurosci Res. 2019 Nov 6. [Epub ahead of print] PubMed PMID: 31692015
  • Pelak VS, Berman BD. Transient Daily Episodes of Vision Loss Due to Parkinson's Disease. Neuroophthalmology. 2019 Aug;43(4):260-264. PubMed PMID: 31528193
  • Berman BD, Hawkins T. Author response: Pimavanserin: A novel therapeutic option for Parkinson disease psychosis. Neurol Clin Pract. 2018 Jun;8(3):175-176. PubMed PMID: 30105152
  • Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease. Mov Disord. 2018 Nov;33(11):1760-1768. PubMed PMID: 30306618
  • Junker J, Brandt V, Berman BD, Vidailhet M, Roze E, Weissbach A, Comella C, Malaty IA, Jankovic J, LeDoux MS, Berardelli A, Barbano R, Reich SG, Perlmutter JS, Jinnah HA, Brüggemann N. Predictors of alcohol responsiveness in dystonia. Neurology. 2018 Nov 20;91(21):e2020-e2026. PubMed PMID: 30341158
  • McConnell BV, Kaplan RI, Teale PD, Kronberg E, Broussard JL, Guzetti JR, Sillau SH, Dhanasekaran AR, Kluger BM, Berman BD. Feasibility of home-based automated transcranial electrical stimulation during slow wave sleep. Brain Stimul. 2019 May - Jun;12(3):813-815. PubMed PMID: 30819658

Professional Memberships

  • Movement Disorder Society, Member
  • American Academy of Neurology, Member
  • Society for Neuroscience, Member
  • Sigma Xi, Member
  • American Neurological Association, Member
  • Parkinson Study Group, Member

Specialty Information

Specialties
  • Neurology, Board Certification (2009)
  • Radiology, Board Certification (1999)
Conditions & Treatments
  • Brain and Nervous System - Parkinson's Disease
  • Brain and Nervous System
  • Brain and Nervous System - Movement Disorders
Clinical Interests
My clinical interests include a variety of movement disorders including Parkinson’s disease, dystonia, tremor, chorea and ataxia. I diagnose, care for, and treat patients with these conditions and perform botulinum toxin injections for dystonia, tardive syndromes, spasticity, and drooling. I also see patients with movement disorders and other neurological conditions at the Denver VA Medical Center.

Care Philosophy
I try to apply a humanistic approach to caring for patients, and attempt to empower patients and their families in the medical decision making process. I also try to connect with my patients and incorporate humor into therapeutic interactions as a way to help them learn to accept, improve and cope with their often disabling neurological disorders.

Personal Interests
In my free time I enjoy spending time with my kids and wife, going to concerts, playing guitar, exercising, traveling, scuba diving, and participating in some of the many outdoor activities Colorado has to offer like snowboarding, hiking, biking and camping.

Volunteer Activities
I volunteer my time speaking for patient support and advocacy groups around Colorado, and serve on medical advisory boards for the Benign Essential Blepharospasm Research Foundation and the National Spasmodic Torticollis Association.


School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students